Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Meihua International Medical Technologies Co Ltd (MHUA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: MHUA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -61.68% | Avg. Invested days 26 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 14.36M USD | Price to earnings Ratio 1.13 | 1Y Target Price - |
Price to earnings Ratio 1.13 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.85 | 52 Weeks Range 0.25 - 1.47 | Updated Date 06/29/2025 |
52 Weeks Range 0.25 - 1.47 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.4 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 11.19% | Operating Margin (TTM) 16.33% |
Management Effectiveness
Return on Assets (TTM) 5% | Return on Equity (TTM) 7.09% |
Valuation
Trailing PE 1.13 | Forward PE - | Enterprise Value 6349300 | Price to Sales(TTM) 0.15 |
Enterprise Value 6349300 | Price to Sales(TTM) 0.15 | ||
Enterprise Value to Revenue 0.07 | Enterprise Value to EBITDA 0.4 | Shares Outstanding 31904500 | Shares Floating 15734833 |
Shares Outstanding 31904500 | Shares Floating 15734833 | ||
Percent Insiders 49.95 | Percent Institutions 1.06 |
Upturn AI SWOT
Meihua International Medical Technologies Co Ltd
Company Overview
History and Background
Meihua International Medical Technologies Co Ltd. (MHUA) is a China-based medical device supplier. The company was founded in 2014 and listed on the Nasdaq in 2021. They specialize in manufacturing and distributing a range of medical devices used in hospitals and other healthcare facilities.
Core Business Areas
- Medical Device Manufacturing: Production of disposable medical devices and equipment for use in hospitals and clinics. This includes various types of tubing, valves, and other components.
- Distribution and Sales: Sale and distribution of manufactured medical devices to hospitals, clinics, and other healthcare providers, primarily in China.
- Customized Solutions: Offering customized medical device solutions based on specific client needs and requirements.
Leadership and Structure
The leadership team includes company directors, key executives, and department heads responsible for overseeing the organization's strategic direction and operational efficiency. The organizational structure is hierarchical, with functional departments such as manufacturing, sales, marketing, and finance reporting to senior management.
Top Products and Market Share
Key Offerings
- Disposable Medical Tubing: Various types of disposable medical tubing used for fluid transfer in medical procedures. Market share data is difficult to pinpoint exactly, but disposable medical devices market is highly competitive. Key competitors include Medtronic (MDT) and Cardinal Health (CAH). Estimated revenue contribution unavailable.
- Infusion Sets: Infusion sets for administering fluids and medications to patients intravenously. Market share data is difficult to pinpoint exactly, but infusion sets have a high number of competitors. Key competitors include Becton Dickinson (BDX) and Baxter (BAX). Estimated revenue contribution unavailable.
Market Dynamics
Industry Overview
The medical device industry is experiencing growth driven by an aging population, rising healthcare expenditures, and technological advancements. Increased demand for disposable medical devices, especially due to infection control concerns, is fueling market expansion.
Positioning
Meihua International Medical Technologies Co Ltd. is positioned as a provider of affordable medical devices, primarily catering to the Chinese market. Its competitive advantage lies in its cost-effective manufacturing capabilities and established distribution network.
Total Addressable Market (TAM)
The global medical devices market is estimated to be worth hundreds of billions of dollars. Meihua International Medical Technologies Co Ltd., focusing on a niche within this broad market, holds a relatively small portion of the overall TAM, mainly the disposable medical device part, focusing on the Chinese market.
Upturn SWOT Analysis
Strengths
- Cost-effective manufacturing capabilities
- Established distribution network in China
- Focus on disposable medical devices
- Ability to provide customized solutions
Weaknesses
- Reliance on the Chinese market
- Limited product diversification
- Brand recognition outside of China
- Smaller scale compared to major global players
Opportunities
- Expanding into new geographic markets
- Developing new and innovative medical devices
- Partnering with international distributors
- Capitalizing on increasing healthcare spending in China
Threats
- Intense competition from established players
- Fluctuations in raw material costs
- Changes in regulatory requirements
- Economic downturns affecting healthcare spending
Competitors and Market Share
Key Competitors
- Medtronic (MDT)
- Becton Dickinson (BDX)
- Cardinal Health (CAH)
- Baxter (BAX)
Competitive Landscape
Meihua International Medical Technologies Co Ltd. faces significant competition from larger, more established medical device companies. Its advantages lie in its cost-effective production and focus on the Chinese market, but it needs to address its weaknesses in brand recognition and international expansion to compete effectively.
Growth Trajectory and Initiatives
Historical Growth: Historical growth trends are difficult to ascertain due to limited access to comprehensive data for the company.
Future Projections: Future growth projections based on analyst estimates are not readily available.
Recent Initiatives: Recent strategic initiatives are not readily available.
Summary
Meihua International Medical Technologies Co Ltd. is a small player in the competitive medical device market, primarily operating within China. Its cost-effective manufacturing gives it a competitive edge locally, but it faces challenges due to limited brand recognition and smaller scale. The company needs to focus on strategic initiatives such as international expansion and product diversification to sustain long-term growth. Due to its small presence in the international market and difficulties extracting data, MHUA's strengths and financial data are currently limited.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Research Reports
- Financial News Sources
Disclaimers:
This analysis is based on available information and is subject to change. The data provided is not guaranteed to be accurate or complete. Investment decisions should be made with caution and after consulting with a qualified financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Meihua International Medical Technologies Co Ltd
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2022-02-16 | CEO & Director Mr. Wang Xin | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 619 | Website https://www.meihuamed.com |
Full time employees 619 | Website https://www.meihuamed.com | ||
Meihua International Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of medical devices in the People's Republic of China. The company offers Class I disposable medical devices, including disposable medical X-ray films, medical dry films, dry laser imagers, gauze bandages, examination gloves, pharmaceutical packaging materials and containers, low-density polyethylene bottles for eye drops, and high-density polyethylene bottles for tablets; Class II products, such as disposable full anesthesia kits, medical brush, woman's examination kits, urethral catheterization kits, gynecological examination kits, endotracheal intubation, medical masks, anal bags, and suction connecting tube, etc.; and Class III disposable medical devices, such as disposable infusion pumps, anesthesia puncture kits, electronic pumps, etc. It also offers disposable plastic baby bottles, NB/PSN rubber covers and 8.2mL folded spoons for tools and containers, etc.; Class II 6866 medical polymer materials and products, including transfusion equipment and pipelines, endotracheal intubation for respiratory anesthesia or ventilation; and medical x-ray films and multi-functional self-extracting X-ray film machines. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.